Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histiocytosis-X.

M E Osband, J M Lipton, P Lavin

    The New England Journal of Medicine
    |January 15, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Methods for the use of stromal cells for therapeutic gene therapy.

    Methods in molecular medicine·2014
    Same author

    The impact of ionizing radiation on placental trophoblasts.

    Placenta·2014
    Same author

    Reduced febrile responses to peripheral and central administration of pyrogen in aged squirrel monkeys.

    Neurobiology of aging·2013
    Same author

    A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.

    Lung cancer (Amsterdam, Netherlands)·2013
    Same author

    Modulation of in utero total body irradiation induced newborn mouse growth retardation by maternal manganese superoxide dismutase-plasmid liposome (MnSOD-PL) gene therapy.

    Gene therapy·2011
    Same author

    Methyltransferases mediate cell memory of a genotoxic insult.

    Oncogene·2010
    Same journal

    Ebola at 50 - Lessons for Outbreak Response and Preparedness.

    The New England journal of medicine·2026
    Same journal

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.

    The New England journal of medicine·2026
    Same journal

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients. Reply.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients.

    The New England journal of medicine·2026
    Same journal

    Hypertension Control in Low-Income Patients.

    The New England journal of medicine·2026
    See all related articles

    This study found that calf thymus extract can effectively treat histiocytosis-X, reversing immune abnormalities and leading to remission in most patients. This suggests thymic extract is a promising therapy for this condition.

    Area of Science:

    • Immunology
    • Pediatric Oncology
    • Cell Biology

    Background:

    • Histiocytosis-X (now Langerhans cell histiocytosis) is a rare disorder characterized by immune dysregulation.
    • Patients often exhibit abnormal lymphocyte function, including reduced histamine H2 receptors on T cells, indicating potential suppressor-cell deficiency.

    Purpose of the Study:

    • To investigate the efficacy of calf thymus extract in treating histiocytosis-X.
    • To explore the immunomodulatory effects of thymic extract on lymphocyte abnormalities in affected patients.

    Main Methods:

    • Assessed immunological status in 17 patients with histiocytosis-X, noting lymphocyte cytotoxicity and erythrocyte antibodies.
    • Treated 17 patients with daily intramuscular injections of calf thymus extract.
    • Monitored clinical response and changes in T-cell histamine H2 receptor levels.

    Related Experiment Videos

    Main Results:

    • Twelve of 17 patients showed immunological abnormalities, including a lack of T-cell histamine H2 receptors.
    • Treatment with calf thymus extract resulted in complete remission in 10 patients.
    • Clinical response correlated with normalization of T-cell histamine H2 receptors and other immune markers.

    Conclusions:

    • Calf thymus extract demonstrates significant therapeutic potential for histiocytosis-X, comparable to chemotherapy.
    • The extract appears to correct underlying immune defects, specifically T-cell receptor deficiencies.
    • Further prospective clinical trials are warranted to confirm these findings and elucidate immunoregulatory mechanisms.